Ethic Inc.

Position in HLN — Haleon plc

CIK 1780570 NEW YORK, NY

Position in HLN

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$1,052,461

+$177,502 QoQ

Shares Held

105,141

+21.5% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 93.60002282649013.ToString("F0")% Shared 0.ToString("F0")% None 6.399977173509858.ToString("F0")%

Healthcare · as of Mar 31, 2026

Ethic Inc. holds $17,529,957 across 9 Drug Manufacturers - Specialty & Generic names. HLN ranks #6 (6.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TAK	Takeda Pharmaceutical Co Ltd	334,836	$6,201,162
2	ZTS	Zoetis Inc.	38,751	$4,580,755
3	RDY	Dr Reddys Laboratories Ltd	120,027	$1,662,373
4	ELAN	Elanco Animal Health Inc	64,231	$1,537,047
5	VTRS	Viatris Inc	90,477	$1,222,344
6	HLN	Haleon plc This page	105,141	$1,052,461
7	UTHR	UNITED THERAPEUTICS Corp	1,078	$639,232
8	TEVA	Teva Pharmaceutical Industries Ltd	19,605	$590,502

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,052,461	105,141	+21.5%	Shares	Sole	2026-04-27
2025-12-31	$874,959	86,544	-8.9%	Shares	Sole	2026-02-03
2025-09-30	$851,692	94,949	+4.5%	Shares	Sole	2025-10-17
2025-06-30	$942,560	90,893	-11.9%	Shares	Sole	2025-07-30
2025-03-31	$1,061,794	103,187	-23.3%	Shares	Sole	2025-05-13
2024-12-31	$1,283,234	134,511	-1.3%	Shares	Sole	2025-02-14
2024-09-30	$1,441,990	136,294	+15.9%	Shares	Sole	2024-11-13
2024-06-30	$971,384	117,601	-13.7%	Shares	Sole	2024-08-13
2024-03-31	$1,157,136	136,294	-20.0%	Shares	Sole	2024-05-13
2023-12-31	$1,402,630	170,429	+97.4%	Shares	Sole	2024-02-14
2023-09-30	$719,170	86,335	+10.1%	Shares	Sole	2023-11-14
2023-06-30	$656,866	78,385	-2.5%	Shares	Sole	2023-08-14
2023-03-31	$654,089	80,355	-30.7%	Shares	Sole	2023-05-12
2022-12-31	$928,240	116,030	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.